A synthetic peptide for use as a blocking control in assays to test for specificity of FLII antibody, Alternative Names: FLII control peptide, FLII antibody Blocking Peptide, Anti-FLII Blocking Peptide, Flightless I Homolog Blocking Peptide, FLI Blocking Peptide, FLIL Blocking Peptide, Fli1 Blocking Peptide, MGC39265 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
FLII
(Flightless I Homolog (FLII))
Synonyme
FLI Peptide, FLIL Peptide, Fli1 Peptide, 3632430F08Rik Peptide, Fliih Peptide, im:7141769 Peptide, DKFZp459O043 Peptide, flightless Peptide, FLII, actin remodeling protein Peptide, flightless I actin binding protein Peptide, protein flightless-1 homolog Peptide, FLII, actin remodeling protein S homeolog Peptide, Protein flightless-1 homolog Peptide, FLII Peptide, Flii Peptide, flii Peptide, LOC585336 Peptide, LOC100640615 Peptide, flii.S Peptide, fli-1 Peptide
Hintergrund
FLII is a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. This gene is located within the Smith-Magenis syndrome region on chromosome 17.